Robeco Institutional Asset Management B.V. Sells 214 Shares of Dolby Laboratories, Inc. (NYSE:DLB)

Robeco Institutional Asset Management B.V. trimmed its position in Dolby Laboratories, Inc. (NYSE:DLB) by 0.1% during the fourth quarter, according to its most recent 13F filing with the SEC. The fund owned 196,142 shares of the electronics maker’s stock after selling 214 shares during the period. Robeco Institutional Asset Management B.V.’s holdings in Dolby Laboratories were worth $15,319,000 as of its most recent filing with the SEC.

A number of other hedge funds have also recently bought and sold shares of DLB. Bank of Montreal Can boosted its position in shares of Dolby Laboratories by 45.0% in the 2nd quarter. Bank of Montreal Can now owns 30,788 shares of the electronics maker’s stock worth $2,465,000 after purchasing an additional 9,558 shares during the last quarter. Cubist Systematic Strategies LLC bought a new position in shares of Dolby Laboratories in the 2nd quarter worth $146,000. Millennium Management LLC boosted its position in shares of Dolby Laboratories by 177.6% in the 2nd quarter. Millennium Management LLC now owns 48,415 shares of the electronics maker’s stock worth $3,836,000 after purchasing an additional 30,977 shares during the last quarter. Sanctuary Advisors LLC bought a new position in shares of Dolby Laboratories in the 2nd quarter worth $2,460,000. Finally, Handelsbanken Fonder AB boosted its position in shares of Dolby Laboratories by 66.1% in the 3rd quarter. Handelsbanken Fonder AB now owns 21,616 shares of the electronics maker’s stock worth $1,654,000 after purchasing an additional 8,600 shares during the last quarter. 58.56% of the stock is currently owned by institutional investors.

Insider Buying and Selling at Dolby Laboratories

In related news, SVP John D. Couling sold 7,000 shares of Dolby Laboratories stock in a transaction dated Monday, November 25th. The stock was sold at an average price of $80.50, for a total transaction of $563,500.00. Following the completion of the transaction, the senior vice president now owns 106,806 shares in the company, valued at approximately $8,597,883. This trade represents a 6.15 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, CAO Ryan Nicholson sold 10,500 shares of Dolby Laboratories stock in a transaction dated Tuesday, November 26th. The stock was sold at an average price of $80.18, for a total value of $841,890.00. Following the transaction, the chief accounting officer now owns 24,364 shares of the company’s stock, valued at $1,953,505.52. The trade was a 30.12 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 135,917 shares of company stock valued at $10,877,739 in the last 90 days. 38.39% of the stock is currently owned by company insiders.

Dolby Laboratories Trading Down 4.2 %

Shares of Dolby Laboratories stock opened at $83.63 on Friday. The company has a market capitalization of $7.98 billion, a PE ratio of 30.75 and a beta of 0.98. Dolby Laboratories, Inc. has a 12 month low of $66.35 and a 12 month high of $89.66. The stock’s fifty day simple moving average is $79.35 and its 200 day simple moving average is $75.76.

Dolby Laboratories Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Wednesday, February 19th. Shareholders of record on Tuesday, February 11th will be paid a $0.33 dividend. This represents a $1.32 annualized dividend and a dividend yield of 1.58%. The ex-dividend date of this dividend is Tuesday, February 11th. Dolby Laboratories’s dividend payout ratio is 48.53%.

Analyst Upgrades and Downgrades

DLB has been the topic of several recent research reports. Rosenblatt Securities restated a “buy” rating and issued a $100.00 price target on shares of Dolby Laboratories in a research report on Thursday. StockNews.com lowered Dolby Laboratories from a “strong-buy” rating to a “buy” rating in a research report on Friday. Finally, Barrington Research reaffirmed an “outperform” rating and set a $100.00 price objective on shares of Dolby Laboratories in a research note on Monday, January 27th.

About Dolby Laboratories

Dolby Laboratories, Inc creates audio and imaging technologies that transform entertainment at the cinema, DTV transmissions and devices, mobile devices, OTT video and music services, home entertainment devices, and automobiles. The company develops and licenses its audio technologies, such as AAC & HE-AAC, a digital audio codec solution used for a range of media applications; AVC, a digital video codec with high bandwidth efficiency used in various media devices; Dolby AC-4, a digital audio coding technology that delivers new audio experiences to a range of playback devices; and Dolby Atmos technology for cinema and various media devices.